DE69417957D1 - Chinolin-3-essigsäure-derivate, verfahren zu deren herstellung und anwendung - Google Patents

Chinolin-3-essigsäure-derivate, verfahren zu deren herstellung und anwendung

Info

Publication number
DE69417957D1
DE69417957D1 DE69417957T DE69417957T DE69417957D1 DE 69417957 D1 DE69417957 D1 DE 69417957D1 DE 69417957 T DE69417957 T DE 69417957T DE 69417957 T DE69417957 T DE 69417957T DE 69417957 D1 DE69417957 D1 DE 69417957D1
Authority
DE
Germany
Prior art keywords
acetic acid
neurosis
cataract
halogen
chinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69417957T
Other languages
English (en)
Other versions
DE69417957T2 (de
Inventor
Tomoji Aotsuka
Toshiyuki Nishio
Hiroshi Hosono
Yoshiyuki Nakamura
Tetsuo Matsui
Hiromichi Ishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Welfide Corp
Original Assignee
Senju Pharmaceutical Co Ltd
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Welfide Corp filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69417957D1 publication Critical patent/DE69417957D1/de
Application granted granted Critical
Publication of DE69417957T2 publication Critical patent/DE69417957T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69417957T 1993-01-06 1994-01-06 Chinolin-3-essigsäure-derivate, verfahren zu deren herstellung und anwendung Expired - Fee Related DE69417957T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP01589993A JP3195455B2 (ja) 1993-01-06 1993-01-06 キノリン−３−酢酸誘導体、その製造法と用途
PCT/JP1994/000007 WO1994015934A1 (en) 1993-01-06 1994-01-06 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof

Publications (2)

Publication Number Publication Date
DE69417957D1 true DE69417957D1 (de) 1999-05-27
DE69417957T2 DE69417957T2 (de) 1999-09-16

Family

ID=11901633

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69417957T Expired - Fee Related DE69417957T2 (de) 1993-01-06 1994-01-06 Chinolin-3-essigsäure-derivate, verfahren zu deren herstellung und anwendung

Country Status (12)

Country Link
US (1) US5543420A (de)
EP (1) EP0633261B1 (de)
JP (1) JP3195455B2 (de)
KR (1) KR950700289A (de)
CN (1) CN1102040A (de)
AT (1) ATE179172T1 (de)
AU (1) AU667426B2 (de)
CA (1) CA2131370A1 (de)
DE (1) DE69417957T2 (de)
ES (1) ES2130403T3 (de)
TW (1) TW287162B (de)
WO (1) WO1994015934A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
CN101058558B (zh) * 2007-05-28 2013-04-10 沈阳药科大学 具有醛糖还原酶抑制活性的4-氧代-1(4h)-喹啉羧酸类化合物、组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
TW202450B (de) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co
US5262433A (en) * 1991-08-06 1993-11-16 Wakamoto Pharmaceutical Co., Ltd. Tetrazoleacetic acid derivatives and method of aldose reductase inhibition therewith

Also Published As

Publication number Publication date
US5543420A (en) 1996-08-06
CN1102040A (zh) 1995-04-26
KR950700289A (ko) 1995-01-16
AU667426B2 (en) 1996-03-21
EP0633261A1 (de) 1995-01-11
EP0633261B1 (de) 1999-04-21
ATE179172T1 (de) 1999-05-15
JPH06199851A (ja) 1994-07-19
ES2130403T3 (es) 1999-07-01
JP3195455B2 (ja) 2001-08-06
DE69417957T2 (de) 1999-09-16
CA2131370A1 (en) 1994-07-21
AU5823394A (en) 1994-08-15
WO1994015934A1 (en) 1994-07-21
TW287162B (de) 1996-10-01
EP0633261A4 (de) 1995-04-12

Similar Documents

Publication Publication Date Title
ATE134998T1 (de) Diphenylmethanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
PT798295E (pt) Novo derivado de amidinonaftilo ou sal deste
DE69417957D1 (de) Chinolin-3-essigsäure-derivate, verfahren zu deren herstellung und anwendung
NO971743D0 (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
DE69418961D1 (de) Benzothiazol-derivate, verfahren zur herstellung sowie anwendungen
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
DE69424295D1 (de) Bernsteinsäuremonoamidverbindung, verfahren zur deren herstellung und deren verwendung
EP0644194A4 (de) Pyridothiazinessigsäure-derivate, verfahren zu deren herstellung sowie deren verwendung.
DE69300318T2 (de) Flavonderivate.
DK0613897T3 (da) Piperidinderivater med anti-histamin-og anti-leukotrienaktivitet
EP0738727A4 (de) 1,4-benzoxazin-2-essigsäureverbindung, verfahren zu ihrer herstellung und ihre verwendung
EP0794184A4 (de) 6-methoxy-1h-benzotriazol-5-carboxamide-derivate, verfahren zur herstellung und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee